Haemonetics Corporation (HAE) Q2 2008 Earnings Results

Haemonetics Corp Misses on EPS, Stock Up 1.54%

Despite missing EPS expectations, Haemonetics Corp's stock rose by 1.54%, indicating that investors may be optimistic about the company's long-term prospects. The management's focus on innovation and growth could be driving this positive sentiment. However, the lack of revenue data and guidance leaves some uncertainty for investors.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.45	N/A	-5.26%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management remains positive about future opportunities. They emphasized their commitment to innovation and market expansion.

Management expressed confidence in long-term growth despite the EPS miss.

They highlighted ongoing investments in product development.

Haemonetics Corp Misses on EPS, Stock Up 1.54%

Key numbers

Management commentary

Haemonetics Corporation

More earnings this week

Haemonetics Corp Misses on EPS, Stock Up 1.54%

Key numbers

Management commentary